SHIFTBIO is a biotechnology company revolutionizing next-generation drug delivery systems (DDS) using natural nanoparticles (NNPs). Through a proprietary AI-driven NNP design platform, we have achieved precise payload delivery to specific cells and tissues. Moreover, we have established a large-scale manufacturing process applicable to diverse cell origins, ensuring high yield, quality, and batch-to-batch consistency for clinical applications. Our AI technology mitigates risks from drug discovery to clinical applications.
Company Details
- Employees
- 22
- Founded
- -
- Address
- 성북구 화랑로 76, 서울특별시,02751,korea, Republic Of
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.shiftbio.net/
- HQ
- 서울특별시
Shiftbio Inc. Questions
Shiftbio Inc.'s website is https://www.shiftbio.net/
Shiftbio Inc.'s LinkedIn profile is https://kr.linkedin.com/company/shiftbio
Shiftbio Inc. has
22 employees.
View email and phone details for 22
employees at Shiftbio Inc..
Shiftbio Inc.'s industry is
Biotechnology Research
Shiftbio Inc.'s top competitors are
Eti B D.o.o.,
Shift Bioscience,
Sk Biopharmaceuticals,
Illimis Therapeutics,
Cha Bio Group｜차바이오그룹,
Exopharm Ltd,
Lmntic Biotech,
Roosterbio Inc.,
Fortuga Bio,
Hanall Biopharma.
Shiftbio Inc.'s categories are Biotechnology Research
Shiftbio Inc.'s founding year is 2020
